Lung cancer rates lower at higher elevations
the ONA take:
According to a new study published in the journal Peerj, researchers from the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania, and the University of California Department of Biological and Medical Informatics in San Francisco, California, have found that lung cancer rates are lower at higher elevations, suggesting that atmospheric oxygen may have a role in lung carcinogenesis.
For the study, the researchers sought to investigate whether inhaled oxygen could be a carcinogen by analyzing cancer incidence rates across the Western United States.
They found that as the county elevation increased, lung cancer rates decreased. Specifically, lung cancer incidence decreased by 7.23 cases per 100,000 individuals for every 1,000-meter elevation increasing. The researchers accounted for various variables, such as smoking prevalence and education.
The authors note, however, that the observed association does not prove a causal effect between oxygen and lung cancer. They also evaluated rates of breast, colorectal, and prostate cancer, and found a weak association or no association between elevation and incidence.
The findings will probably not persuade individuals to relocate, but the identification of a universal and major risk factor for lung cancer may lead to better treatments and preventative approaches.
Lung cancer rates are lower at higher elevations, suggesting that atmospheric oxygen may have a role in lung carcinogenesis.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|